Do you want to bring your CAR NK cell and Treg cell research into clinical applications?
Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR NK cell and Treg-based therapies – from basic research to process development and clinical manufacturing. Discover the products, tools and services that build on Miltenyi Biotec’s expertise to move your CAR NK and Treg projects forward.
- Understand the process to isolate primary human NK cells or regulatory T cells for basic research and clinical manufacturing
- Gain insights into the efficient activation, genetic modification, and expansion of NK cells
- Discover an automated, GMP-compliant enrichment and expansion platform that attains clinically relevant numbers of Treg cells
- Get an overview of cell analysis solutions based on flow cytometry
